BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,870 | -22.9% | 10,489 | -7.0% | 0.03% | -21.4% |
| Q2 2023 | $513,612 | +12.4% | 11,273 | +0.1% | 0.04% | +10.5% |
| Q1 2023 | $456,889 | +55.7% | 11,265 | +95.6% | 0.04% | +46.2% |
| Q4 2022 | $293,464 | -5.0% | 5,758 | +0.5% | 0.03% | -13.3% |
| Q3 2022 | $309,000 | -16.0% | 5,731 | +0.1% | 0.03% | -9.1% |
| Q2 2022 | $368,000 | -17.1% | 5,726 | +0.1% | 0.03% | -5.7% |
| Q1 2022 | $444,000 | -9.6% | 5,722 | +0.1% | 0.04% | +2.9% |
| Q4 2021 | $491,000 | +1.9% | 5,718 | -4.5% | 0.03% | -12.8% |
| Q3 2021 | $482,000 | 0.0% | 5,990 | +0.1% | 0.04% | +2.6% |
| Q2 2021 | $482,000 | -4.6% | 5,985 | +0.1% | 0.04% | -20.8% |
| Q1 2021 | $505,000 | +5.2% | 5,982 | +0.1% | 0.05% | -4.0% |
| Q4 2020 | $480,000 | 0.0% | 5,978 | +0.1% | 0.05% | -12.3% |
| Q3 2020 | $480,000 | -6.6% | 5,975 | +0.1% | 0.06% | -14.9% |
| Q2 2020 | $514,000 | -5.5% | 5,971 | -10.9% | 0.07% | -16.2% |
| Q1 2020 | $544,000 | -8.0% | 6,698 | -5.2% | 0.08% | +29.0% |
| Q4 2019 | $591,000 | -8.7% | 7,065 | -4.6% | 0.06% | -13.9% |
| Q3 2019 | $647,000 | +13.5% | 7,402 | +6.4% | 0.07% | +9.1% |
| Q2 2019 | $570,000 | +0.7% | 6,959 | +0.0% | 0.07% | 0.0% |
| Q1 2019 | $566,000 | +23.6% | 6,956 | +0.0% | 0.07% | +10.0% |
| Q4 2018 | $458,000 | -14.6% | 6,953 | +0.0% | 0.06% | 0.0% |
| Q3 2018 | $536,000 | +25.2% | 6,950 | +20.0% | 0.06% | +20.0% |
| Q2 2018 | $428,000 | +16.6% | 5,791 | +2.7% | 0.05% | +13.6% |
| Q1 2018 | $367,000 | +0.5% | 5,641 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $365,000 | -6.6% | 5,641 | -9.4% | 0.04% | -12.0% |
| Q3 2017 | $391,000 | +3.7% | 6,226 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $377,000 | +32.7% | 6,226 | +13.7% | 0.05% | +28.2% |
| Q1 2017 | $284,000 | +26.2% | 5,478 | +7.9% | 0.04% | +14.7% |
| Q4 2016 | $225,000 | -7.0% | 5,078 | 0.0% | 0.03% | -20.9% |
| Q3 2016 | $242,000 | +5.2% | 5,078 | 0.0% | 0.04% | +2.4% |
| Q2 2016 | $230,000 | +10.0% | 5,078 | 0.0% | 0.04% | +5.0% |
| Q1 2016 | $209,000 | +1.0% | 5,078 | -6.4% | 0.04% | 0.0% |
| Q4 2015 | $207,000 | +158.8% | 5,428 | +123.6% | 0.04% | +150.0% |
| Q3 2015 | $80,000 | -52.9% | 2,428 | 0.0% | 0.02% | -48.4% |
| Q2 2015 | $170,000 | +1.8% | 2,428 | -0.4% | 0.03% | 0.0% |
| Q1 2015 | $167,000 | -6.2% | 2,438 | +0.4% | 0.03% | -8.8% |
| Q4 2014 | $178,000 | +2.3% | 2,428 | 0.0% | 0.03% | -2.9% |
| Q3 2014 | $174,000 | -1.1% | 2,428 | 0.0% | 0.04% | 0.0% |
| Q2 2014 | $176,000 | -1.7% | 2,428 | 0.0% | 0.04% | -5.4% |
| Q1 2014 | $179,000 | – | 2,428 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |